Giancarlo Comi, Jeffrey A. Cohen, Douglas L. Arnold, Daniel Wynn, Massimo Filippi and for the FORTE Study Group Phase III dose-comparison study of glatiramer acetate for multiple sclerosis Annals of Neurology 69
Article first published online: 28 JAN 2011 | DOI: 10.1002/ana.22316
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.